The company has predicted that Imaavy — now approved for generalized myasthenia gravis — could eventually earn more than $5 ...

“Optimal Biotech Group is thrilled to collaborate with Sunflower Therapeutics on their groundbreaking in-vessel perfusion technology, enabling continuous biomass feeding, fluid harvesting, and cell ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

At Mleiha Wheat Farm in Sharjah, experts have developed a wheat variety with 19.3% protein content, potentially boosting the ...

Discover six hemophilia companies developing new treatments for the genetic bleeding disorder, from gene therapies to RNAi ...

The financing will enable Nova Anchora to advance its lead candidate NvA-011, a recombinant collagen therapy, through IND-enabling studies. The investment underscores the backers’ commitment to ...

Animal-free egg protein intended to alleviate egg shortages will be coming from a biotech firm building its first plant in ...

Researchers have discovered a new biomarker for Parkinson's disease. A misfolded protein facilitates reliable diagnosis even in the early stages of Parkinson's disease in body fluids.

According to data compiled by S&P Global Market Intelligence, Kymera Therapeutics ( KYMR -0.86%) notched an almost 23% share price gain across this week. That made it a standout in the ever-volatile ...

Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this ...